- Home
- MOLN vs EVBN Comparison
MOLN vs EVBN Comparison
Compare MOLN & EVBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- EVBN
- Stock Information
- Founded
- MOLN 2004
- EVBN 1920
- Country
- MOLN Switzerland
- EVBN United States
- Employees
- MOLN N/A
- EVBN 266
- Industry
- MOLN
- EVBN Major Banks
- Sector
- MOLN
- EVBN Finance
- Exchange
- MOLN Nasdaq
- EVBN Nasdaq
- Market Cap
- MOLN 183.2M
- EVBN 194.4M
- IPO Year
- MOLN 2021
- EVBN N/A
- Fundamental
- Price
- MOLN $4.10
- EVBN N/A
- Analyst Decision
- MOLN
- EVBN Hold
- Analyst Count
- MOLN 0
- EVBN 1
- Target Price
- MOLN N/A
- EVBN $45.50
- AVG Volume (30 Days)
- MOLN 25.8K
- EVBN 20.1K
- Earning Date
- MOLN 03-06-2025
- EVBN 05-13-2025
- Dividend Yield
- MOLN N/A
- EVBN 3.34%
- EPS Growth
- MOLN N/A
- EVBN N/A
- EPS
- MOLN N/A
- EVBN 2.16
- Revenue
- MOLN $5,484,562.00
- EVBN $68,410,000.00
- Revenue This Year
- MOLN N/A
- EVBN $13.08
- Revenue Next Year
- MOLN $866.67
- EVBN N/A
- P/E Ratio
- MOLN N/A
- EVBN $18.30
- Revenue Growth
- MOLN N/A
- EVBN N/A
- 52 Week Low
- MOLN $3.36
- EVBN $24.07
- 52 Week High
- MOLN $12.70
- EVBN $46.21
- Technical
- Relative Strength Index (RSI)
- MOLN 52.08
- EVBN 8.36
- Support Level
- MOLN $3.79
- EVBN $38.03
- Resistance Level
- MOLN $4.27
- EVBN $39.68
- Average True Range (ATR)
- MOLN 0.27
- EVBN 0.65
- MACD
- MOLN 0.04
- EVBN -4.32
- Stochastic Oscillator
- MOLN 66.07
- EVBN 0.00
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About EVBN Evans Bancorp Inc.
Evans Bancorp Inc is a financial holding company. Through its subsidiaries, it provides various banking services to consumers and commercial customers in the USA. The firm operates through a single business segment throughout Western New York and Finger Lakes Region, which derives interest and fee income.